Self-Administered Parenteral Market Report: Trends, Forecast and Competitive Analysis to 2030

Self-Administered Parenteral Market Report: Trends, Forecast and Competitive Analysis to 2030

Self-Administered Parenteral Trends and Forecast

The future of the global self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets. The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Self-Administered Parenteral by Segment

The study includes a forecast for the global self-administered parenteral by product type, usage, distribution channel, application, and region.

Self-Administered Parenteral Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Pre-Filled Syringes
• Auto injectors
• Pen Injectors
• Others

Self-Administered Parenteral Market by Usage [Shipment Analysis by Value from 2018 to 2030]:

• Disposable
• Reusable

Self-Administered Parenteral Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Online Pharmacies
• Home Healthcare Providers
• Specialty Clinics
• Others

Self-Administered Parenteral Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cardiovascular Diseases
• Diabetes
• Osteoporosis
• Pain Management
• Hormone Replacement
• Others

Self-Administered Parenteral Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Self-Administered Parenteral Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies self-administered parenteral companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the self-administered parenteral companies profiled in this report include-

• Becton, Dickinson and Company
• scPharmaceuticals
• Harro Höfliger
• Owen Mumford
• Haselmeier
• Stevanato Group
• Ypsomed AG
• Solteam Group
• AstraZeneca
• Enable Injections

Self-Administered Parenteral Market Insights

Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.

Within this market, pain management is expected to witness the highest growth over the forecast period.

APAC is expected to witness the highest growth over the forecast period.

Features of the Global Self-Administered Parenteral Market

Market Size Estimates: Self-administered parenteral market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Self-administered parenteral market size by various segments, such as by product type, usage, distribution channel, application, and region in terms of value ($B).

Regional Analysis: Self-administered parenteral market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, usages, distribution channels, applications, and regions for the self-administered parenteral market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the self-administered parenteral market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for self-administered parenteral market?

Answer: The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the self-administered parenteral market?

Answer: The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.

Q3. What are the major segments for self-administered parenteral market?

Answer: The future of the self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets.

Q4. Who are the key self-administered parenteral market companies?

Answer: Some of the key self-administered parenteral companies are as follows:

• Becton, Dickinson and Company
• scPharmaceuticals
• Harro Höfliger
• Owen Mumford
• Haselmeier
• Stevanato Group
• Ypsomed AG
• Solteam Group
• AstraZeneca
• Enable Injections

Q5. Which self-administered parenteral market segment will be the largest in future?

Answer: Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.

Q6. In self-administered parenteral market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the self-administered parenteral market by product type (pre-filled syringes, auto injectors, pen injectors, and others), usage (disposable and reusable), distribution channel (hospital pharmacies, online pharmacies, home healthcare providers, specialty clinics, and others), application (cardiovascular diseases, diabetes, osteoporosis, pain management, hormone replacement, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.